Effects of Early Erythropoietin Therapy on the Transfusion Requirements of Preterm Infants Below 1250 Grams Birth Weight: A Multicenter, Randomized, Controlled Trial
- 1 October 2001
- journal article
- clinical trial
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 108 (4) , 934-942
- https://doi.org/10.1542/peds.108.4.934
Abstract
Objectives.: Infants of ≤1250 g birth weight receive multiple erythrocyte transfusions during their hospitalization. We hypothesized that early erythropoietin (Epo) and iron therapy would 1) decrease the number of transfusions received (infants 401-1000 g birth weight; trial 1) and 2) decrease the percentage of infants who received any transfusions (1001–1250 g birth weight; trial 2).Methods.: A total of 172 infants in trial 1 and 118 infants in trial 2 were randomized to treatment (Epo, 400 U/kg 3 times weekly) or placebo/control. Therapy was initiated by 4 days after birth and continued through the 35th postmenstrual week. All infants received supplemental parenteral and enteral iron. Complete blood and reticulocyte counts were measured weekly, and ferritin concentrations were measured monthly. Transfusions were administered according to protocol. Phlebotomy losses and transfusion data were recorded.Results.: Treated and placebo/control infants in trial 1 received a similar number of transfusions (4.3 ± 3.6 vs 5.2 ± 4.2, respectively). A similar percentage of treated and control infants in trial 2 received at least 1 transfusion (37% vs 46%). Reticulocyte counts were higher in treated infants during each week of the study in both trials. Hematocrits were higher among treated infants from week 2 on in both trials. Ferritin concentrations were higher in placebo/controls than in treated infants at weeks 4 and 8 in trial 1 and at week 4 in trial 2. No adverse effects of Epo or supplemental iron occurred.Conclusion.: The combination of early Epo and iron as administered in this study stimulated erythropoiesis in infants who were ≤1250 g at birth. However, the lack of impact on transfusion requirements fails to support routine use of early Epo.neonate, intravenous iron, donor exposure.Keywords
This publication has 37 references indexed in Scilit:
- Changing patterns of red blood cell transfusion in very low birth weight infantsThe Journal of Pediatrics, 1996
- A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietinThe Journal of Pediatrics, 1996
- Late-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research NetworkThe Journal of Pediatrics, 1996
- Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition solutionThe Journal of Pediatrics, 1996
- Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurityThe Journal of Pediatrics, 1995
- Prospective, randomized trial of the safety and efficacy of a limited donor exposure transfusion program for premature neonatesThe Journal of Pediatrics, 1994
- Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the “anemia of prematurity”The Journal of Pediatrics, 1988
- Anemia of prematurity: Determinants of the erythropoietin responseThe Journal of Pediatrics, 1984
- Decreased response of plasma immunoreactive erythropoietin to “available oxygen” in anemia of prematurityThe Journal of Pediatrics, 1984
- Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gmThe Journal of Pediatrics, 1978